Heart protection study

Current Cardiology Reports

Volumn 4, Issue 6, 2002, Pages 486-487

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879225558     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Schwartz GG, Olsson AG, Ezekowitz MD, et al.: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285:1711-1718.
2. Sacks FM: Lipid-lowering therapy in acute coronary syndromes. JAMA 2001, 285:1758-1760.
3. Brown BG, Zhao XQ, Chait A, et al.: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001, 345:1583-1592.
4. Freedman JE: Antioxidant versus lipid-altering therapy-some answers, more questions. N Engl J Med 2001, 345:1636-1637.
5. Rubins HB, Robins SJ, Collins D, et al.: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999, 341:410-418.
6. Rader DJ: A new feature on the cholesterol-lowering landscape. Nat Med 2001, 7:1282-1284.
7. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:23-33.
8. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7-22.
9. Hutchison SJ, Reitz MS, Sudhir K, et al.: Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits. Hypertension 1997, 29:1186-1191.